Vtesse Pharma
Developed VTS-270 to treat patients with Niemann-Pick Disease Type C.
Launch date
Employees
Market cap
-
Enterprise valuation
$68—102m (Dealroom.co estimates Jul 2016.)
Gaithersburg Maryland (HQ)
Authorizing premium user...